Showing 1 - 20 results of 110 for search '"Deepak L. Bhatt"', query time: 0.55s Refine Results
  1. 1
    Clopidogrel resistance – A clear problem with an unclear solution

    Clopidogrel resistance – A clear problem with an unclear solution by Sameer Bansilal, Deepak L. Bhatt

    Published 2012-07-01
    Get full text
    Article
  2. 2
    Birth and Maturation of Cardio-Oncology

    Birth and Maturation of Cardio-Oncology by Deepak L. Bhatt, MD, MPH

    Published 2019-09-01
    Get full text
    Article
  3. 3
    Recruitment Practices in Multicenter Randomized Clinical Trials: Time for a Relook

    Recruitment Practices in Multicenter Randomized Clinical Trials: Time for a Relook by Prakriti Gaba, Deepak L. Bhatt

    Published 2021-11-01
    Get full text
    Article
  4. 4
    Are Patients Getting Their Aspirin's Worth in Ischemic Stroke?

    Are Patients Getting Their Aspirin's Worth in Ischemic Stroke? by Alec A. Schmaier, Deepak L. Bhatt

    Published 2018-06-01
    Get full text
    Article
  5. 5
    Generalizability of the SURPASS‐2 Trial and Effect of Tirzepatide on US Diabetes and Obesity Control

    Generalizability of the SURPASS‐2 Trial and Effect of Tirzepatide on US Diabetes and Obesity Control by Nicholas Chiu, Rahul Aggarwal, Deepak L. Bhatt

    Published 2022-08-01
    Get full text
    Article
  6. 6
    Addressing bias: artificial intelligence in cardiovascular medicine

    Addressing bias: artificial intelligence in cardiovascular medicine by Emily Tat, Deepak L Bhatt, Mark G Rabbat

    Published 2020-12-01
    Get full text
    Article
  7. 7
    Women and Diabetes: Preventing Heart Disease in a New Era of Therapies

    Women and Diabetes: Preventing Heart Disease in a New Era of Therapies by Giuseppe Galati, Pierre Sabouret, Olga Germanova, Deepak L Bhatt

    Published 2021-10-01
    Get full text
    Article
  8. 8
    Procedure room innovation during the COVID-19 crisis: Protecting healthcare workers while learning from history

    Procedure room innovation during the COVID-19 crisis: Protecting healthcare workers while learning from history by Dinesh Vyas, Kayla K. Umemoto, Arpita Vyas, Deepak L. Bhatt

    Published 2022-08-01
    Get full text
    Article
  9. 9
    Meta-Analysis of Contemporary Trials of Omega-3 Fatty Acids Containing Both Eicosapentaenoic and Docosahexaenoic Acids

    Meta-Analysis of Contemporary Trials of Omega-3 Fatty Acids Containing Both Eicosapentaenoic and Docosahexaenoic Acids by Safi U. Khan, MD, MS, Deepak L. Bhatt, MD, MPH

    Published 2021-09-01
    Get full text
    Article
  10. 10
    Early initiation of SGLT2 inhibitors is important, irrespective of ejection fraction: SOLOIST‐WHF in perspective

    Early initiation of SGLT2 inhibitors is important, irrespective of ejection fraction: SOLOIST‐WHF in perspective by Subodh Verma, Stefan D. Anker, Javed Butler, Deepak L. Bhatt

    Published 2020-12-01
    Get full text
    Article
  11. 11
    Cardiovascular Safety Assessment in Cancer Drug Development

    Cardiovascular Safety Assessment in Cancer Drug Development by Ohad Oren, Tomas G. Neilan, Michael G. Fradley, Deepak L. Bhatt

    Published 2021-12-01
    Get full text
    Article
  12. 12
    Self-employment and cardiovascular risk in the US general population

    Self-employment and cardiovascular risk in the US general population by Chayakrit Krittanawong, Anirudh Kumar, Zhen Wang, Usman Baber, Deepak L. Bhatt

    Published 2020-09-01
    Get full text
    Article
  13. 13
    Contemporary National Patterns of Eligibility and Use of Novel Lipid‐Lowering Therapies in the United States

    Contemporary National Patterns of Eligibility and Use of Novel Lipid‐Lowering Therapies in the United States by Miles Shen, Arash Aghajani Nargesi, Khurram Nasir, Deepak L. Bhatt, Rohan Khera

    Published 2022-09-01
    Get full text
    Article
  14. 14
    Generalizability of FIGARO‐DKD and FIDELIO‐DKD Trial Criteria to the US Population Eligible for Finerenone

    Generalizability of FIGARO‐DKD and FIDELIO‐DKD Trial Criteria to the US Population Eligible for Finerenone by Nicholas Chiu, Rahul Aggarwal, George L. Bakris, Bertram Pitt, Deepak L. Bhatt

    Published 2022-04-01
    Get full text
    Article
  15. 15
    Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure

    Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure by Anna Meta Dyrvig Kristensen, Manan Pareek, Michael Hecht Olsen, Deepak L Bhatt

    Published 2020-02-01
    Get full text
    Article
  16. 16
    Comparative Effects of Mineral Oil, Corn Oil, Eicosapentaenoic Acid, and Docosahexaenoic Acid in an In Vitro Atherosclerosis Model

    Comparative Effects of Mineral Oil, Corn Oil, Eicosapentaenoic Acid, and Docosahexaenoic Acid in an In Vitro Atherosclerosis Model by Samuel C. R. Sherratt, Peter Libby, Deepak L. Bhatt, R. Preston Mason

    Published 2023-04-01
    Get full text
    Article
  17. 17
    On the use of propensity scores in case of rare exposure

    On the use of propensity scores in case of rare exposure by David Hajage, Florence Tubach, Philippe Gabriel Steg, Deepak L. Bhatt, Yann De Rycke

    Published 2016-03-01
    Get full text
    Article
  18. 18
    Pleiotropic Effects of Influenza Vaccination

    Pleiotropic Effects of Influenza Vaccination by Astrid Johannesson Hjelholt, Cecilia Bergh, Deepak L. Bhatt, Ole Fröbert, Mads Fuglsang Kjolby

    Published 2023-08-01
    Get full text
    Article
  19. 19
    SOTAGLIFLOZIN SIGNIFICANTLY REDUCES CARDIOVASCULAR DEATH, MYOCARDIAL INFARCTION, AND STROKE IN THE SCORED TRIAL

    SOTAGLIFLOZIN SIGNIFICANTLY REDUCES CARDIOVASCULAR DEATH, MYOCARDIAL INFARCTION, AND STROKE IN THE SCORED TRIAL by Deepak L. Bhatt, Michael Szarek, Bertram Pitt, Ph Gabriel Steg, on behalf of the SCORED Investigators

    Published 2023-03-01
    Get full text
    Article
  20. 20
    Population pharmacokinetic–pharmacodynamic modeling of PB2452, a monoclonal antibody fragment being developed as a ticagrelor reversal agent, in healthy volunteers

    Population pharmacokinetic–pharmacodynamic modeling of PB2452, a monoclonal antibody fragment being developed as a ticagrelor reversal agent, in healthy volunteers by Steven J. Kathman, Jeffery J. Wheeler, Deepak L. Bhatt, Susan E. Arnold, John S. Lee

    Published 2022-01-01
    Get full text
    Article

Search Tools: